February 2, 2026: FDA Posts Updated Safety Label for Mounjaro On January 20, 2026, the FDA posted an updated safety/warning label with new patient information for those taking Mounjaro (tirzepatide)
These side effects are typically transient and resolve on their own without requiring intervention
Immune System Support: Glutathione strengthens the immune system by promoting the production of white blood cells and protecting them from oxidative damage
placebo, 11.3%) (17)
They highlight that inadvertent intravascular injection, high cumulative dosing, and patient factors (extremes of age, cardiac, hepatic, or renal disease, pregnancy) are major contributors, and that bupivacaine carries the greatest cardiotoxic risk
Key Ingredients & Benefits: Methionine Supports liver health and helps prevent fat buildup while aiding in lipid metabolism and energy production